HomeInsightsEPS

Ipca Laboratories Ltd EPS

Ipca Laboratories Ltd EPS

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

1.7 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Ipca Laboratories Ltd

NSE: IPCALAB

EPS

₹ 26.47

Last updated on: Dec 26, 2024

Key Highlights

  • The Earning per Share of Ipca Laboratories Ltd is ₹ 26.47 as of 26 Dec 24 .
  • The earning per share of Ipca Laboratories Ltd changed from ₹ 5.64 to ₹ 9.05 over 10 quarters. This represents a CAGR of 20.82% .

Historical Earning per Share of Ipca Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Ipca Laboratories Ltd

Market Cap

40,423 Cr

EPS

26.5

P/E Ratio (TTM) *

60.2

P/B Ratio (TTM) *

6.0

Day’s High *

1612.5

Day’s Low

1589.15

DTE *

0.2

ROE *

9.9

52 Week High

1708.7

52 Week Low

1053.45

ROCE *

14.0

Market Price of Ipca Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Ipca Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20241593.35
24 Dec 20241582.25
23 Dec 20241585.6
20 Dec 20241584.25
19 Dec 20241593.45
18 Dec 20241516.05
17 Dec 20241557.8
16 Dec 20241564.9
13 Dec 20241534.55
12 Dec 20241559.95

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ipca Laboratories Ltd

Market Value

40,424

Asset Value

5,103

6.9 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Ipca Laboratories Ltd2640,423
Sun Pharmaceuticals Industries Ltd464,41,838
Divis Laboratories Ltd691,56,107
Cipla Ltd571,20,270
Mankind Pharma Ltd511,20,212
Torrent Pharmaceuticals Ltd511,15,638

Historical Market Cap of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Ipca Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Ipca Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories to voluntarily close its wholly owned subsidiary in Mexico

Ipca Laboratories has received necessary approval for voluntary closure of its wholly owne...

Read more

04 Dec 2024 16:57

News

Ipca Laboratories Ltd up for third straight session

Ipca Laboratories Ltd gained for a third straight session today. The stock is quoting at R...

Read more

19 Nov 2024 13:05

News

Board of Ipca Laboratories recommends Interim Dividend

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held...

Read more

14 Nov 2024 15:29

News

Ipca Labs rises as Q2 PAT climbs 58% YoY to Rs 229 cr

Profit before tax surged 53.01% to Rs 344.83 crore in the September 2024 quarter from Rs 2...

Read more

14 Nov 2024 14:54

News

Ipca Laboratories schedules board meeting

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

25 Oct 2024 11:15

News

Board of Ipca Laboratories approves consolidation of USA generic formulations biz

The Board of Ipca Laboratories at its meeting held on 30 September 2024 has approved enter...

Read more

30 Sep 2024 18:44

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

June 2024

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

Aug 2023

Transcript

Apr 2023

Transcript

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Mar 2021

Transcript

Nov 2020

Transcript

Aug 2020

Transcript

June 2020

Transcript

Feb 2020

Transcript

FAQs for EPS of Ipca Laboratories Ltd

What is the EPS of Ipca Laboratories Ltd stock?

The Earnings Per Share (EPS) of Ipca Laboratories Ltd is 26.47. An EPS is the amount of net income attributed to each share of a common stock.

How is Ipca Laboratories Ltd EPS calculated?

The EPS of Ipca Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Ipca Laboratories Ltd report its EPS?

Ipca Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Ipca Laboratories Ltd EPS?

Factors that influence the EPS of Ipca Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Ipca Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Ipca Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions